The treatment of Alzheimer's Disease & Macular Degeneration with vitamins

Alzheimer's Disease and Macular Degeneration: Mitamins custom make quality formulas for the treatment of Alzheimer's Disease & Macular Degeneration with vitamins. A Alzheimer's Disease & Macular Degeneration formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Alzheimer's Disease and Macular Degeneration

  • Amount Per Serving
    % DV
    Vitamin A
    2500
    IU
    50%
    Vitamin C
    200
    mg
    333%
    Vitamin E
    200
    IU
    667%
    Thiamin
    50
    mg
    3333%
    Vitamin B12
    125
    mcg
    2083%
    Zinc
    10
    mg
    67%
    Flax Seed Powder
    50
    mg
    *
  • Amount Per Serving
    % DV
    Lutein
    500
    mcg
    *
    Ginkgo Extract
    40
    mg
    *
    Grape Seed Extract
    50
    mg
    *
    Acetyl L-Carnitine
    250
    mg
    *
    Phosphatidylserine
    100
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Alzheimer's Disease and Macular Degeneration
Serving Size:4-5

Alzheimer's Disease and Macular Degeneration Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
As Huntington's Disease Awareness Month Commences, A New Drug Offers Hope To Pre-Symptomatic Sufferers
With May's Huntington's Disease Awareness Month as a backdrop, the Avicena Group, a California based biotech company, is set to launch a clinical trial for a new drug therapy, HD-02, with the ultimate aim of delaying the onset of this incurable, fatal disease. If successful, this compound would signal a significant advancement in the treatment of Huntington's disease and finally provide hope for 150,000 Americans who are carriers of the deadly Huntington's gene.
Almost a Third of U.S. Kids Use Supplements (HealthDay)
More than 30 percent of American children take some kind of dietary supplement, mostly multivitamins and multiminerals, a U.S. National Institutes of Health study finds.
This information concerning the support of Alzheimer's Disease and Macular Degeneration treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments